LianBio (LIAN) Comparison with companies in other sectors?

LianBio has a share price of 107.17M. You can analyze LianBio (LIAN) competitors across different market sectors through stock heatmaps.

What are LIAN's NET and operating margins?

LianBio (LIAN) operating margin is around 0.00, and net profit margin is approximately 0.00 as of the latest reports.

In what way does LIAN's earnings per share (EPS) trend reflect its financial momentum?

LianBio (LIAN) EPS is -0.82 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for LianBio is -0.39, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for LianBio?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for LianBio like P/E which is -0.31, P/B which is 0.13, and PEG which is -0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

LianBio

LIAN•NASDAQ

Healthcare

Biotechnology

$0.32

$-0.03(-8.28%)

Fundamental Analysis of LianBio (LIAN)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.82

P/E Ratio

-0.39

ROE

-0.36%

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$34.19M

Shares OutstandingTotal number of shares issued

$107.17M

Book Value/ShareNet worth per share

$2.72

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.82

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

-35.96%

ROAReturn on total assets

-34.47%

ROCEReturn on capital employed

-42.30%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$-0.94

Cash/ShareCash and equivalents per share

$2.80

FCF YieldFree cash flow as percentage of market cap

-295.53%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.43

Dividend YieldAnnual dividend as percentage of stock price

134.80%

Financial Ratios Analysis data is not available for LIANFinancial Ratios Analysis details for LIAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for LIANSector Benchmarking details for LIAN are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for LianBio Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of LianBio. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account LianBio's unique business strengths and challenges.

Key Financial Metrics for LianBio

For LianBio, essential financial indicators include EPS -0.82, PE -0.39, and ROE -0.36. These key ratios reveal insights into LianBio's profitability, valuation, and operational health. Understanding these metrics enables you to compare LianBio with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of LianBio

Metrics like Net Margin - and ROA -34.47% shed light on how well LianBio is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether LianBio can sustain its operations and continue growing in the future.

Valuation and Market Position of LianBio

Using ratios such as P/B Ratio 0.13 and PEG Ratio -0.00, investors can assess whether LianBio is appropriately valued based on its financials and growth potential. These figures, combined with LianBio's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for LianBio

Financial health indicators, such as Debt/Equity Ratio 0.02 and Cash Flow $-0.94, provide a snapshot of LianBio's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like LianBio, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for LianBio

Investing in LianBio based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at LianBio focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;